Articles From: Actua to Acquire FolioDynamix, a Cloud-Based Wealth Management Technology Platform to Acxiom to Discuss Second Quarter Earnings


RADNOR, Pa., Sept.
Sign-up for Actua to Acquire FolioDynamix, a Cloud-Based Wealth Management Technology Platform investment picks
RADNOR, Pa., Sept.
Sign-up for Actua's September 24th Investor Conference Streamed Live via Video Webcast investment picks
Actuant Corporation (NYSE: ATU) today announced results for its fourth quarter and fiscal year ended August 31, 2014.
Sign-up for Actuant Reports Fourth Quarter and Full Year Fiscal 2014 Results; Provides 2015 Guidance; New Share Repurchase Program Announced investment picks
Actuate Corporation (NASDAQ:BIRT), The BIRT Company™ and the leader in personalized analytics and insights, today announced the 15 Excellence Awards winners for 2014 from around the globe.
Sign-up for Actuate Announces 2014 Customer Excellence Award Winners for Embedded Analytics investment picks
Today at Data Driven Summit 2014 , Actuate Corporation (NASDAQ:BIRT) - The BIRT Company™ and the leader in personalized analytics and insights, announced new features to its Embedded Analytics solution that delivers ease of use, scalability and productivity for global enterprises that need to tap the variety, velocity and volume of big data and deliver real-time actionable information to their customers on any device.
Sign-up for Actuate Broadens Embedded Analytics Solution to Bring the Power of Big Data to Mobile Customers investment picks
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Actuate Corp.
Sign-up for ACTUATE CORP. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Actuate Corp. Over the Proposed Sale of the Company to Open Text Corp. - BIRT investment picks
2014/12/5
WILMINGTON, Del.
Sign-up for ACTUATE CORPORATION SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout investment picks
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Actuate Corporation (“Actuate”) (NASDAQ:BIRT) concerning the sale to OpenText Corporation.
Sign-up for ACTUATE CORPORATION, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Sale to OpenText Corporation investment picks
Actuate Corporation (NASDAQ: BIRT), The BIRT Company™ and the leader in personalized analytics and insights, today announced financial results for the third quarter 2014: Third Quarter 2014 Financial and Operational Highlights: Total non-GAAP revenue of $24.4 million; Total license revenue of $6.2 million; Subscription bookings of $1.8 million; Booked 28 subscription deals; Non-GAAP operating income of $334,000; Non-GAAP fully diluted EPS of $0.01; Total cash and short-term investments of $58.3 million on September 30, 2014.
Sign-up for Actuate Reports Third Quarter 2014 Financial Results investment picks
Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating whether members of the board of directors of Actuate Corporation (NASDAQ: BIRT) breached their fiduciary duties in connection with the planned merger of the Company with OpenText Corporation.
Sign-up for ACTUATE SHAREHOLDER ALERT: Johnson & Weaver, LLP Investigates the Fairness of Price and Process in Proposed Sale of Actuate Corporation, Inc. to OpenText investment picks
Actuate Corporation (NASDAQ:BIRT), The BIRT Company™ and the leader in personalized analytics and insights, today announced that it has entered into an agreement to be acquired by OpenText.
Sign-up for Actuate Signs Agreement to be Acquired by OpenText investment picks
Actuate Corporation (NASDAQ: BIRT) – the leader in embedded analytics, today announced the lineup of keynote speakers and technically focused breakout sessions for its annual customer conference, Data Driven Summit 2014 , taking place in the following cities: Santa Clara on Nov.
Sign-up for Actuate to Address the Future of Embedded Analytics at Data Driven Summit 2014 investment picks
Actuate Corporation (NASDAQ:BIRT), The BIRT Company ™ and the leader in personalized analytics and insights, today announced it will deliver its third quarter 2014 financial results on Tuesday, November 4, 2014.
Sign-up for Actuate to Announce Third Quarter 2014 Results on November 4 investment picks
Actuate Corporation (NASDAQ:BIRT) - The BIRT Company™ and innovator in document accessibility technology, Braille Works – a leading provider of alternative reading formats for the visually impaired, and Venatôre – a trusted federal government information technology solutions provider, announced a collaboration to deliver Cloud508 , the industry’s first¹ cloud-based document accessibility service for U.S. federal government agencies.
Sign-up for Actuate, Braille Works and Venatôre Collaborate to Deliver Industry’s First Cloud-Based Document Accessibility Service investment picks
Actuate Corporation (NASDAQ:BIRT), The BIRT Company™ and the leader in personalized analytics and insights, today announced its participation in an upcoming TDWI webinar called, “Making Data Beautiful for Business Users: Tips for Creating Rich, Visual and Actionable User Experiences.” Allen Bonde ( @abonde ), Actuate’s VP of Product Marketing and Innovation, and David Stodder ( @dbstodder ), TDWI’s Research Director for Business Intelligence, will share best practices and current technology trends.
Sign-up for Actuate's Allen Bonde and TDWI’s David Stodder to Discuss Creating Rich User Experiences in Complimentary Webinar on September 23 investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G025318-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/11/3/11G025318/Acura_Pharmaceuticals,_Inc.-6733629489.jpg PALATINE, IL--(Marketwired - November 03, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse, announced today financial results for the three and nine months ended September 30, 2014.
Sign-up for Acura Pharmaceuticals Announces Third Quarter 2014 Financial Results investment picks
http://media.marketwire.com/attachments/201209/51329_acura.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1147540&ProfileId=051205&sourceType=1 PALATINE, IL --
Sign-up for Acura Pharmaceuticals Hydrocodone Bitartrate With Acetaminophen Tablets Meet Clinical Endpoints investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G023919-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/10/15/11G023919/Acura_Pharmaceuticals,_Inc.-6733629489.jpg PALATINE, IL--(Marketwired - October 16, 2014) - Acura Pharmaceuticals Inc. (NASDAQ: ACUR) announced today that the US Food and Drug Administration (FDA) has denied on procedural grounds Acura's appeal of the position taken by Division of Anesthesia, Analgesia, and Addiction Products (DAAAP) that abuse by snorting of hydrocodone with acetaminophen products lacks relevance.
Sign-up for Acura Pharmaceuticals Provides Update on Its Hydrocodone Bitartrate With Acetaminophen Tablets Development investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G027946-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/12/5/11G027946/Acura_Pharmaceuticals,_Inc.-6733629489.jpg PALATINE, ILL--(Marketwired - December 08, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs , today announced that the Company has been issued U.S. Patent No.
Sign-up for Acura Pharmaceuticals Receives Additional U.S. Patent for Abuse Deterrent Drug Formulations investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G024813-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/10/28/11G024813/Acura_Pharmaceuticals,_Inc.-6733629489.jpg PALATINE, IL--(Marketwired - October 28, 2014) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs , today announced that the Company plans to report financial results for the third quarter 2014 following the close of financial markets on Monday, November 3, 2014.
Sign-up for Acura Pharmaceuticals to Host Third Quarter 2014 Financial Results Conference Call on November 4, 2014 investment picks
Acxiom® (NASDAQ: ACXM), an enterprise data, analytics and software-as-a-service company, today announced a strategic partnership with Weibo Corporation (Weibo), China’s leading social media platform.
Sign-up for Acxiom and Weibo Launch Big Data Marketing Platform “Audience Onboard” investment picks
Acxiom® (Nasdaq: ACXM), an enterprise data, analytics and software-as-a-service Company, today announced financial results for its second quarter ended September 30, 2014.
Sign-up for Acxiom Announces Second Quarter Results investment picks
Acxiom® (NASDAQ: ACXM), an enterprise data, analytics and software-as-a-service company, today announced that it has awarded a research grant to The Information Accountability Foundation (IAF) to expand its work on the Ethical Big Data Framework to the marketing and advertising industry.
Sign-up for Acxiom Awards Grant to Create Framework for Ethical Use of Big Data investment picks
Acxiom® (NASDAQ: ACXM), an enterprise data, analytics and software-as-a-service company, today announced three strategic hires, further strengthening its executive bench.
Sign-up for Acxiom Boosts Key Strategic Offerings investment picks
Acxiom® (Nasdaq: ACXM), an enterprise data, analytics and software-as-a-service Company, today announced that its Board of Directors voted to extend the duration of the Company's existing share repurchase program for an additional year, through November 12, 2015.
Sign-up for Acxiom Extends Share Repurchase Program investment picks
Acxiom® (NASDAQ:ACXM), an enterprise data, analytics and software-as-a-service company, today announced it has joined the Salesforce Analytics Cloud Ecosystem to provide consumer recognition, data assets and value-added analytic insights to users, improving critical decision processes, and driving improvement in overall business results.
Sign-up for Acxiom Joins New Salesforce Analytics Cloud Ecosystem to Drive Consumer Data into the Heart of Business Decision-Making investment picks
Acxiom® (NASDAQ: ACXM), an enterprise data, analytics and software-as-a-service company, today announced a company-wide program to unlock the power of data to bring relief to pressing community challenges associated with health, education and humanitarian aid.
Sign-up for Acxiom Launches Program to Leverage its Data Power for Community Wellness investment picks
Acxiom® Corporation (Nasdaq: ACXM) expects to issue its fiscal year 2015 second quarter earnings release on Monday, November 3, after the financial markets close.
Sign-up for Acxiom to Discuss Second Quarter Earnings investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Actua to Acquire FolioDynamix, a Cloud-Based Wealth Management Technology Platform to Acxiom to Discuss Second Quarter Earnings
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent